Neonatal Mortality and Morbidity of Twin-Twin Transfusion Syndrome.
10.5385/jksn.2012.19.1.32
- Author:
Ju sun HEO
1
;
Curie KIM
;
Yoon Joo KIM
;
Seung Han SHIN
;
Jae Myung LEE
;
Juyoung LEE
;
Jin A SOHN
;
Jin A LEE
;
Chang Won CHOI
;
Ee Kyung KIM
;
Han Suk KIM
;
Beyong Il KIM
;
Jung Hwan CHOI
Author Information
1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. kimhans@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Twin-twin transfusion syndrome;
Infant mortality;
Morbidity;
Neonatal intensive care
- MeSH:
Acute Kidney Injury;
Case-Control Studies;
Early Intervention (Education);
Gestational Age;
Heart Failure;
Hemorrhage;
Humans;
Hypertrophy;
Incidence;
Infant;
Infant Mortality;
Infant, Newborn;
Intensive Care, Neonatal;
Leukomalacia, Periventricular;
Retrospective Studies;
Tissue Donors
- From:Journal of the Korean Society of Neonatology
2012;19(1):32-40
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study was aimed to evaluate the neonatal mortality and morbidity of infants affected by twin-twin transfusion syndrome (TTTS) compared to the control twins matched for gestational age. Also the perinatal outcomes of donor parts of TTTS twins with their counterpart recipients were compared. METHODS: A retrospective case-control study was conducted from infants born at Seoul National University Children's Hospital and Seoul National University Bundang Hospital between April 2005 and July 2011. Eighteen pairs of TTTS infants were allocated to the TTTS group. The control group consisted of 36 pairs of twin infants unaffected by TTTS who were matched for gestational age. Neonatal deaths and morbidities were recorded. RESULTS: The mortality in TTTS group was significantly higher than control group (27.8% vs. 4.2%, P=0.001). The incidence of acute renal failure (41.2% vs. 9.7%, P<0.001), cardiac ventricular hypertrophy (31.3% vs. 2.9%, P<0.001), congestive heart failure (45.7% vs. 5.6%, P<0.001), grade > or =2 intraventricular hemorrhage (33.3% vs. 11.1%, P=0.012) and grade > or =2 periventricular leukomalacia (24.2% vs. 2.8%, P=0.001) were significantly higher in TTTS group than control group. There was no significant difference in mortality and morbidities between donors and recipients except significantly higher incidence of acute renal failure in donors (70.6% vs. 11.8%, P=0.001). CONCLUSION: Twin infants affected by TTTS have higher risk of neonatal death and several severe morbidities. These results indicate that alert monitoring and checking about possible morbidities are very important in newborns with TTTS and early intervention is critical for improving the overall outcome of the affected infants.
